Brind.

Scott Harris has taken on the role of chief development officer at Terns Pharmaceuticals.

1 report, 1 independent Updated Aug 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Scott Harris has taken on the role of chief development officer at Terns Pharmaceuticals.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Scott Harris

    American health officer and infectious disease expert

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GlobeNewswireTerns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025 Webinar to be held on Wednesday, September 3, 2025 at 4:30 p.